Thema: US56600D1072
MRVI, US56600D1072
wall-street-582921_1920.jpg - Foto: THN
Maravai LifeSciences stock gets November conference update
Lang & Schwarz quoted the share at EUR 7.55 at 10:59 p.m. Berlin time on October 29. The Maravai LifeSciences stock faces new investor events in November.
ad-hoc-news.de, heute 02:49 Uhr
MRVI, US56600D1072
Maravai LifeSciences stock: TD Cowen starts coverage at ...
Q2 revenue reached USD 51.44 million, up 9.00 percent year over year. November 4, 2026 is the next results date for Maravai LifeSciences stock.
ad-hoc-news.de, 23.10.26 00:43 Uhr
MRVI, US56600D1072
TD Cowen's USD 9.00 target leaves Maravai LifeSciences stock ...
Revenue was USD 51.44 million in second quarter 2026. Maravai LifeSciences stock costs USD 6.79 on October 16, 2026, down 3.96 percent on Nasdaq.
ad-hoc-news.de, 17.10.26 22:12 Uhr
MRVI, US56600D1072
TD Cowen starts coverage on Maravai LifeSciences stock at ...
Second-quarter revenue was USD 51.44 million, up 9.00 percent year over year. Maravai LifeSciences stock had EUR 7.00 as prior close on October 5, 2026.
ad-hoc-news.de, 07.10.26 04:13 Uhr
MRVI, US56600D1072
Maravai LifeSciences stock gets a TD Cowen strong buy rating ...
TD Cowen set a USD 9.00 target on October 5, 2026, while MarketBeat reported a strong-buy upgrade the next day. Q2 revenue reached USD 51.44 million.
ad-hoc-news.de, 07.10.26 01:19 Uhr
MRVI, US56600D1072
Maravai secures CleanCap patent and reports on Maravai LifeSciences ...
Maravai LifeSciences stock was EUR 6.73 on October 1, 2026. Q2 revenue was USD 51.44 million, with guidance at USD 33 million-USD 35 million.
ad-hoc-news.de, 01.10.26 12:13 Uhr
MRVI, US56600D1072
Maravai LifeSciences stock gets a USD 8.00 UBS target
Maravai LifeSciences stock posted USD 51.44 million in Q2 revenue versus USD 48.67 million consensus on August 6, 2026. UBS set an USD 8.00 target on September 9.
ad-hoc-news.de, 28.09.26 15:14 Uhr
MRVI, US56600D1072
Maravai LifeSciences stock gains 3.74 percent as market ...
